US2014141439A1PendingUtilityA1

Methods and compositions for identifying increased risk of developing fragile x-associated disorders

53
Assignee: HUTCHINSON FRED CANCER RESPriority: Oct 2, 2007Filed: Oct 31, 2013Published: May 22, 2014
Est. expiryOct 2, 2027(~1.2 yrs left)· nominal 20-yr term from priority
Inventors:Stephen J. TapscottGalina N. FilippovaPaula D. Ladd
C12Q 1/6883C12Q 2600/154C12Q 2600/156C12Q 2600/158C12Q 2600/16
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions and methods of identifying a subject as having an increased risk of developing fragile X-associated tremor and ataxia syndrome (FXTAS) or identifying a subject having an increased risk of developing fragile X syndrome (FXS), comprising analyzing messenger RNA (mRNA) transcripts and/or translation products of the antisense gene ASFMR1.

Claims

exact text as granted — not AI-modified
That which is claimed is: 
     
         1 - 37 . (canceled) 
     
     
         38 . A kit comprising one or more reagents for the detection of an ASFMR1e mRNA transcript comprising the nucleotide sequence of SEQ ID NO:5 or a nucleotide sequence that is at least 95% identical to the nucleotide sequence of SEQ ID NO:5.

Join the waitlist — get patent alerts

Track US2014141439A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.